7929

532321

ZYDUSLIFE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ZYDUS LIFESCIENCES LTD Share Price Today

ZYDUS LIFESCIENCES LTD is currently trading at ₹1076.6, down by ₹1.7 from the previous close. The stock touched an intraday high of ₹1081.10 and a low of ₹1048.90 during the latest trading session. Over the past one year, ZYDUS LIFESCIENCES LTD has delivered a return of 17.58%, while the stock has gained 20.92% in the last one month.

ZYDUS LIFESCIENCES LTD performance

Today’s low Today’s high
₹ 1048.90 ₹ 1081.10
₹ 1079.50
52 week low 52 week high
₹ 835.50 ₹ 1115.50
₹ 1079.50
Open Price ₹ 1078.10
Prev. Close ₹ 1078.30
Volume (Shares) 1227307.00
Total traded value ₹ 13248.77
Upper Circuit ₹ 1186.10
Lower Circuit ₹ 970.50
info

Investment Returns

Over 1 Month 20.92% Over 3 Months 20.32% Over 6 Months 16.52% Over 1 Year 17.58%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ZYDUS LIFESCIENCES LTD fundamentals


  • Market cap (Cr) 1,08,623.00
  • P/E Ratio (TTM) 30.45
  • Beta 0.83
  • Book Value / share 235.25
  • Return on equity 31.29%
  • EPS (TTM) 36.70
  • Dividend yield 0.09%
  • Net profit/quarter (Cr) 1,722.00
info icon alternate text
  • Market cap (Cr) 1,08,260.70
  • P/E Ratio (TTM) 30.45
  • Beta 0.72
  • Book Value / share 235.25
  • Return on equity 31.29%
  • EPS (TTM) 36.70
  • Dividend yield 0.09%
  • Net profit/quarter (Cr) 1,722.00
info icon alternate text

ZYDUS LIFESCIENCES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 3564.60
Operating Expense 2018.20
Net Profit 1722.00
Net Profit Margin (%) 48.30
Earnings Per Share (EPS) 17.11
EBITDA 2377.40
Effective Tax Rate (%) 18.42
Particulars DEC 2025 (Values in Cr)
Revenue 2207.20
Operating Expense 2344.90
Net Profit 296.50
Net Profit Margin (%) 13.43
Earnings Per Share (EPS) 2.95
EBITDA 612.70
Effective Tax Rate (%) 15.86
Particulars SEP 2025 (Values in Cr)
Revenue 2808.80
Operating Expense 1969.10
Net Profit 1156.60
Net Profit Margin (%) 41.17
Earnings Per Share (EPS) 11.49
EBITDA 1693.39
Effective Tax Rate (%) 19.88
Particulars JUN 2025 (Values in Cr)
Revenue 2495.80
Operating Expense 2270.50
Net Profit 384.70
Net Profit Margin (%) 15.41
Earnings Per Share (EPS) 3.82
EBITDA 742.50
Effective Tax Rate (%) 18.99
Particulars MAR 2025 (Values in Cr)
Revenue 5633.50
Operating Expense 2330.30
Net Profit 2813.70
Net Profit Margin (%) 49.94
Earnings Per Share (EPS) 27.96
EBITDA 3958.10
Effective Tax Rate (%) 23.43
Particulars MAR 2026 (Values in Cr)
Revenue 11076.40
Operating Expense 8602.70
Net Profit 3559.80
Net Profit Margin (%) 32.13
Earnings Per Share (EPS) 35.38
EBITDA 5425.99
Effective Tax Rate (%) 18.76
Particulars MAR 2025 (Values in Cr)
Revenue 14590.10
Operating Expense 8367.80
Net Profit 5774.90
Net Profit Margin (%) 39.58
Earnings Per Share (EPS) 57.39
EBITDA 8432.50
Effective Tax Rate (%) 22.42
Particulars MAR 2024 (Values in Cr)
Revenue 10317.60
Operating Expense 7655.09
Net Profit 3441.50
Net Profit Margin (%) 33.35
Earnings Per Share (EPS) 34.01
EBITDA 5134.90
Effective Tax Rate (%) 18.82
Particulars MAR 2023 (Values in Cr)
Revenue 8421.20
Operating Expense 7044.00
Net Profit 1529.20
Net Profit Margin (%) 18.15
Earnings Per Share (EPS) 15.06
EBITDA 2799.00
Effective Tax Rate (%) 24.75
Particulars MAR 2022 (Values in Cr)
Revenue 7590.00
Operating Expense 6532.40
Net Profit 857.90
Net Profit Margin (%) 11.30
Earnings Per Share (EPS) 8.38
EBITDA 1777.50
Effective Tax Rate (%) 26.29
Particulars MAR 2025 (Values in Cr)
Book Value / Share 238.10
ROE % 21.08
ROCE % 24.56
Total Debt to Total Equity 0.09
EBITDA Margin 30.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 197.11
ROE % 20.64
ROCE % 23.94
Total Debt to Total Equity 0.05
EBITDA Margin 29.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 173.08
ROE % 14.05
ROCE % 16.25
Total Debt to Total Equity 0.16
EBITDA Margin 23.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 166.01
ROE % 29.67
ROCE % 14.44
Total Debt to Total Equity 0.29
EBITDA Margin 23.37
Particulars MAR 2021 (Values in Cr)
Book Value / Share 126.88
ROE % 18.30
ROCE % 13.38
Total Debt to Total Equity 0.54
EBITDA Margin 21.01
Particulars MAR 2025 (Values in Cr)
Book Value / Share 210.64
ROE % 31.29
ROCE % 30.47
Total Debt to Total Equity 0.39
EBITDA Margin 55.78
Particulars MAR 2024 (Values in Cr)
Book Value / Share 156.23
ROE % 23.45
ROCE % 22.73
Total Debt to Total Equity 0.37
EBITDA Margin 47.46
Particulars MAR 2023 (Values in Cr)
Book Value / Share 134.78
ROE % 11.38
ROCE % 13.31
Total Debt to Total Equity 0.28
EBITDA Margin 32.06
Particulars MAR 2022 (Values in Cr)
Book Value / Share 129.30
ROE % 8.43
ROCE % 9.84
Total Debt to Total Equity 0.25
EBITDA Margin 26.31
Particulars MAR 2021 (Values in Cr)
Book Value / Share 124.46
ROE % 13.61
ROCE % 12.22
Total Debt to Total Equity 0.32
EBITDA Margin 30.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2956.80
Total Assets 37201.70
Total Liabilities 37201.70
Total Equity 26358.40
Share Outstanding 100
Price to Book Ratio 4.20
Return on Assets (%) 12.16
Return on Capital (%) 15.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1105.10
Total Assets 29280.80
Total Liabilities 29280.80
Total Equity 22101.60
Share Outstanding 100
Price to Book Ratio 6.43
Return on Assets (%) 13.18
Return on Capital (%) 16.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 573.10
Total Assets 25756.40
Total Liabilities 25756.40
Total Equity 19688.30
Share Outstanding 101
Price to Book Ratio 3.65
Return on Assets (%) 7.61
Return on Capital (%) 9.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1106.90
Total Assets 27795.40
Total Liabilities 27795.40
Total Equity 19053.80
Share Outstanding 102
Price to Book Ratio 2.70
Return on Assets (%) 16.14
Return on Capital (%) 19.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 888.30
Total Assets 23884.70
Total Liabilities 23884.70
Total Equity 14929.60
Share Outstanding 102
Price to Book Ratio 3.54
Return on Assets (%) 8.93
Return on Capital (%) 10.93
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 144.10
Total Assets 32316.90
Total Liabilities 32316.90
Total Equity 21190.10
Share Outstanding 100
Price to Book Ratio 4.20
Return on Assets (%) 17.86
Return on Capital (%) 19.56
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 414.40
Total Assets 24084.80
Total Liabilities 24084.80
Total Equity 15716.50
Share Outstanding 100
Price to Book Ratio 6.43
Return on Assets (%) 14.28
Return on Capital (%) 15.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 248.10
Total Assets 20563.60
Total Liabilities 20563.60
Total Equity 13639.40
Share Outstanding 101
Price to Book Ratio 3.65
Return on Assets (%) 7.43
Return on Capital (%) 8.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 302.60
Total Assets 17740.00
Total Liabilities 17740.00
Total Equity 13240.50
Share Outstanding 102
Price to Book Ratio 2.70
Return on Assets (%) 4.83
Return on Capital (%) 5.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 154.00
Total Assets 18463.60
Total Liabilities 18463.60
Total Equity 12744.50
Share Outstanding 102
Price to Book Ratio 3.54
Return on Assets (%) 7.99
Return on Capital (%) 8.86
Particulars MAR 2025 (Values in Cr)
Net Income 6026.70
Cash from Operations 8578.60
Cash from Investing -8372.30
Cash from Financing 2014.20
Net change in Cash 418.60
Free Cash Flow 10291.20
Particulars MAR 2024 (Values in Cr)
Net Income 4838.10
Cash from Operations 4513.70
Cash from Investing -1475.20
Cash from Financing -1810.40
Net change in Cash -57.70
Free Cash Flow 5420.30
Particulars MAR 2023 (Values in Cr)
Net Income 2582.70
Cash from Operations 3280.80
Cash from Investing 1171.20
Cash from Financing -4400.40
Net change in Cash -540.40
Free Cash Flow 4311.70
Particulars MAR 2022 (Values in Cr)
Net Income 5232.30
Cash from Operations 2778.70
Cash from Investing 1154.40
Cash from Financing -868.30
Net change in Cash 2390.20
Free Cash Flow 3981.29
Particulars MAR 2021 (Values in Cr)
Net Income 2284.80
Cash from Operations 3638.00
Cash from Investing -722.50
Cash from Financing -2548.90
Net change in Cash 21.60
Free Cash Flow 4492.00
Particulars MAR 2025 (Values in Cr)
Net Income 7444.70
Cash from Operations 4462.10
Cash from Investing -4503.60
Cash from Financing 1384.50
Net change in Cash -5.10
Free Cash Flow 5367.00
Particulars MAR 2024 (Values in Cr)
Net Income 4239.80
Cash from Operations 2898.00
Cash from Investing -1831.80
Cash from Financing -300.80
Net change in Cash -132.30
Free Cash Flow 3483.40
Particulars MAR 2023 (Values in Cr)
Net Income 2032.20
Cash from Operations 1471.40
Cash from Investing -1959.30
Cash from Financing 827.00
Net change in Cash -54.10
Free Cash Flow 2221.50
Particulars MAR 2022 (Values in Cr)
Net Income 1163.90
Cash from Operations 1580.70
Cash from Investing 768.20
Cash from Financing -1709.80
Net change in Cash 369.10
Free Cash Flow 2122.50
Particulars MAR 2021 (Values in Cr)
Net Income 1688.50
Cash from Operations 2491.00
Cash from Investing -2713.80
Cash from Financing 255.30
Net change in Cash -231.30
Free Cash Flow 3019.60
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 14.58 1.70 270.44 23.12 38.50
BLISS GVS PHARMA LTD. 402.00 32.52 3.56 4252.72 118.35 437.40
CIPLA LTD. 1390.85 27.54 3.26 112352.94 1165.55 1672.20
FERMENTA BIOTECH LIMITED 300.35 13.25 2.17 883.96 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 24.68 4.54 270.44 23.12 38.50
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8724.25 113.94 24.98 21810.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 402.00 43.23 3.68 4252.72 118.35 437.40

ZYDUS LIFESCIENCES LTD shareholding pattern

Holding
6.85%
74.99%
6.94%
11.2%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

ZYDUS LIFESCIENCES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1079.50 0.11 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 1076.80
  • 26 Days 1007.20
  • 10 Days 1057.80
  • 50 Days 971.30
  • 12 Days 1049.80
  • 100 Days 947.60
  • 20 Days 1022.40
  • 200 Days 946.80
1090.63 PIVOT
First Support 1072.37 First Resistance 1109.47 Second Support 1053.53 Second Resistance 1127.73 Third Support 1035.27 Third Resistance 1146.57
RSI 74.27 ADX 62.67 MACD 43.16 Williams % R -12.76 Commodity Channel Index (CCI) 106.29
Date 2026-06-01 Week 1564428.00 Same Day 924559.00 Month 950510.00
1 Year 0.84 3 Year 0.74
Over 1 Month
20.92% down
Over 1 Year
17.58% down
Over 3 Months
20.32% down
Over 3 Years
28.57% down
Over 6 Months
16.52% down
Over 5 Years
11.99% down

ZYDUS LIFESCIENCES LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
24 Jul 2026 1.0 Final 24 Jul 2026 Equity shares
25 Jul 2025 11.0 Final 25 Jul 2025 Equity shares
26 Jul 2024 3.0 Final 26 Jul 2024 Equity shares
28 Jul 2023 6.0 Final 28 Jul 2023 Equity shares
28 Jul 2022 2.5 Final 29 Jul 2022 Equity shares
28 Jul 2021 3.5 Final 30 Jul 2021 Equity shares
23 Mar 2020 3.5 Interim 24 Mar 2020 Equity shares
25 Jul 2019 3.5 Final 29 Jul 2019 Equity shares
31 Jul 2018 3.5 Final 02 Aug 2018 Equity shares
16 Mar 2017 3.2 Interim 17 Mar 2017 Equity shares
17 Mar 2016 3.2 Interim 18 Mar 2016 Equity shares
30 Jul 2015 12.0 Final 03 Aug 2015 Equity shares
17 Jul 2014 9.0 Final 21 Jul 2014 Equity shares
11 Jun 2013 7.5 Interim 12 Jun 2013 Equity shares
26 Jul 2012 7.5 Final 30 Jul 2012 Equity shares
07 Jul 2011 6.25 Final 11 Jul 2011 Equity shares
15 Jul 2010 5.0 Final 19 Jul 2010 Equity shares
16 Jul 2009 4.5 Final 20 Jul 2009 Equity shares
10 Jul 2008 4.5 Final 14 Jul 2008 Equity shares
12 Jul 2007 4.0 Final 16 Jul 2007 Equity shares
14 Jul 2005 0.0 Final 18 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
06 Apr 2010 05 Apr 2010 1:2
31 Aug 2006 30 Aug 2006 1:1
Ex-Date Old FV NEW FV Record Date
06 Oct 2015 5.0 1.0 07 Oct 2015
Dividend date Dividend amount Dividend type Record date Instrument type
24 Jul 2026 1.0 Final 24 Jul 2026 Equity shares
25 Jul 2025 11.0 Final 25 Jul 2025 Equity shares
26 Jul 2024 3.0 Final 26 Jul 2024 Equity shares
28 Jul 2023 6.0 Final 28 Jul 2023 Equity shares
28 Jul 2022 2.5 Final 29 Jul 2022 Equity shares
28 Jul 2021 3.5 Final 30 Jul 2021 Equity shares
23 Mar 2020 3.5 Interim 24 Mar 2020 Equity shares
25 Jul 2019 3.5 Final 29 Jul 2019 Equity shares
31 Jul 2018 3.5 Final 02 Aug 2018 Equity shares
16 Mar 2017 3.2 Interim 17 Mar 2017 Equity shares
17 Mar 2016 3.2 Interim 18 Mar 2016 Equity shares
30 Jul 2015 12.0 Final 03 Aug 2015 Equity shares
17 Jul 2014 9.0 Final 21 Jul 2014 Equity shares
11 Jun 2013 7.5 Interim 12 Jun 2013 Equity shares
26 Jul 2012 7.5 Final 30 Jul 2012 Equity shares
07 Jul 2011 6.25 Final 11 Jul 2011 Equity shares
15 Jul 2010 5.0 Final 19 Jul 2010 Equity shares
16 Jul 2009 4.5 Final 20 Jul 2009 Equity shares
10 Jul 2008 4.5 Final 14 Jul 2008 Equity shares
12 Jul 2007 4.0 Final 16 Jul 2007 Equity shares
14 Jul 2005 0.0 Final 18 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
06 Apr 2010 05 Apr 2010 1:2
31 Aug 2006 30 Aug 2006 1:1
Ex-Date Old FV NEW FV Record Date
06 Oct 2015 5.0 1.0 07 Oct 2015

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zydus Lifesciences Ltd?

Answer Field

Zydus Lifesciences Ltd share price is for NSE ₹ 1,076.60 & for BSE ₹ 1,075.90 as on Jun 03 2026 03:30 PM.

What is the Market Cap of Zydus Lifesciences Ltd Share?

Answer Field

The market cap of Zydus Lifesciences Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Jun 03 2026 03:30 PM.

What is the 52 Week High and Low of Zydus Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Zydus Lifesciences Ltd for NSE is ₹ 1,115.50 and ₹ 835.50 and for BSE is ₹ 1,115.00 and ₹ 835.85.

What is 1 year return for Zydus Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been 16.19%.

What is the P/E Ratio of Zydus Lifesciences Ltd Share?

Answer Field

As on Jun 03 2026 03:30 PM the price-to-earnings (PE) ratio for Zydus Lifesciences Ltd share is 30.45.

What is the PB ratio of Zydus Lifesciences Ltd Share?

Answer Field

As on Jun 03 2026 03:30 PM, the price-to-book (PB) ratio for Zydus Lifesciences Ltd share is 235.25.

How to Buy Zydus Lifesciences Ltd Share?

Answer Field

You can trade in Zydus Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zydus Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Zydus Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zydus Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|